Both in Pharmaceuticals
Seres Therapeutics vs AYTU BioPharma
Over the past year MCRB returned −88.5% and AYTU returned −9.2%; their daily moves had a correlation of 0.12.
MCRB −88.5% AYTU −9.2%Growth of $1, one year, split-adjusted
| Metric | MCRB | AYTU |
|---|---|---|
| Price | $1.95 | $1.98 |
| Market cap | $19.6M | $21.5M |
| Today | +8.94% | +0.51% |
| 1 month | −41.8% | −7.5% |
| 6 months | −73.5% | −23.3% |
| Year to date | −86.9% | −23.8% |
| 1 year | −88.6% | −8.8% |
| Revenue growth (YoY) | — | +6.4% |
| Gross margin | 100.0% | 64.6% |
| Net margin | 622.4% | −0.1% |
| P/E (TTM) | — | — |
| Price / sales | 10.4× | 0.4× |
| Net cash | $15.6M | $9.3M |
| Dividend yield | — | — |
| Volatility (60d) | 68.6% | 36.9% |
| Short % of float | 4.4% | 3.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).